Anderson-Fabry disease, also known as Fabry disease, is a rare genetic disease that can affect many parts of the body, including the kidneys, hearts and skin. Fabry disease is one of a group of conditions known as lysosomal storage disease. The genetic mutation that causes Fabry disease interferes with the function of any enzyme that processes biomolecules known as sphingolipids, leading to these substances building up in the walls of blood vessels and other organ. It is inherited in an X-linked manner.
Symptoms are typically first experienced in early childhood and can be very difficult to understand; the rarity of Fabry disease to many clinicians sometimes leads to misdiagnoses. Manifestations of the disease usually increase in number and severity at an individual age. The treatment for Fabry disease varies depending on the organs affected by the condition, and the underlying cause can be addressed by replacing the enzyme that is lacking.
To learn more about the diagnosis and treatment of Anderson-Fabry disease and join Fabry patient group, please write to us at patients@apricusbiopharm.com
了解更多法布瑞氏症相关信息及加入病友群，敬请邮件联系:bd@apricusbiopharm.com